SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-16-036945
Filing Date
2016-08-10
Accepted
2016-08-10 07:03:13
Documents
4
Period of Report
2016-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 KMPH-8K_20160810 kmph20160809_8k.htm 8-K 26388
2 KMPH-PR_20160810 ex99-1.htm EX-99.1 192370
3 g201603102022249399711.jpg GRAPHIC 3070
4 g201603102022249399710.jpg GRAPHIC 1727
  Complete submission text file 0001437749-16-036945.txt   226849
Mailing Address 2656 CROSSPARK ROAD, SUITE 100 CORALVILLE IA 52241
Business Address 2656 CROSSPARK ROAD, SUITE 100 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 161819945
SIC: 2834 Pharmaceutical Preparations